
Switzerland-based Basilea Pharmaceutica on Tuesday nominated Domenico Scala as the new chairman of the board. The current Chairman, Martin Nicklasson …
The FDA has given the OK to Astellas and Basilea for their new treatment in adults with a rare but …

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …
GlaxoSmithKline has paid £146 million for Basilea Pharmaceutica’s dermatology drug Toctino. Toctino (alitretinoin) is approved for the treatment of adults …
Specialist Swiss pharma company Basilea has announced a doubling of its revenues in 2009, thanks to the launch of its …
Swiss pharma company Basilea Pharmaceutica has unveiled encouraging interim financial results, showing it has doubled its sales and decreased its …

